JAK1/2 Inhibition Restores Tissue Integrity by Rewiring Type 1/2 Immunity Toward Targetable IL-17 Responses
Regina Jin, Karoline Strobl, Lena Artner-Gent, Johannes Tuechler, Marina Gladkova, Ulrike Mann, Matthias Farlik, Iros Barozzi, Maria Sibilia, Thomas Bauer
This study shows JAK1/2 inhibition reduces pathogenic immune responses and restores tissue integrity in chronic skin inflammation by shifting immunity toward IL-17 responses.
bioRxiv · Nov 2, 2026 · PreprintImmunology